Quantum Computing Could Reshape Israel’s Drug Development Landscape
Israeli scholar David Adler says quantum computing could erode Israeli companies’ computational advantage in AI-driven drug development if it makes molecular simulation more accurate, faster and more accessible. Israel’s Classiq and Japan’s Shionogi have begun related research, but quantum computing has yet to demonstrate a direct advantage in discovering new drugs.

